<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>97(8)</volume><submitter>Osunkwo I</submitter><funding>Novartis Pharmaceuticals Corporation</funding><pubmed_abstract>The international Sickle Cell World Assessment Survey (SWAY) reported a high impact of sickle cell disease (SCD) on patients' daily lives globally. In this study, we analyzed whether the reported burden differed between patients from the USA (n = 384) and other high-income (HI; n = 820) or low- to middle-income (LMI; n = 941) countries. We assessed symptoms and complications, incidence/management of vaso-occlusive crises (VOCs), treatment utilization/satisfaction, and the impact of SCD on education/employment. Certain symptoms (bone aches, insomnia, and joint stiffness) and complications (swollen/painful fingers/toes, gallstones, vision problems, blood clots, and asthma) were reported proportionally more by patients in the USA than in the HI/LMI countries. Self-reported VOCs were more comm</pubmed_abstract><journal>American journal of hematology</journal><pagination>1055-1064</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9540420</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey.</pubmed_title><pmcid>PMC9540420</pmcid><pubmed_authors>Osunkwo I</pubmed_authors><pubmed_authors>Trimnell C</pubmed_authors><pubmed_authors>Bailey T</pubmed_authors><pubmed_authors>El-Rassi F</pubmed_authors><pubmed_authors>Paulose J</pubmed_authors><pubmed_authors>Nero A</pubmed_authors><pubmed_authors>James J</pubmed_authors><pubmed_authors>Minniti CP</pubmed_authors><pubmed_authors>Andemariam B</pubmed_authors><pubmed_authors>Ramscar N</pubmed_authors><pubmed_authors>Rajkovic-Hooley O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey.</name><description>The international Sickle Cell World Assessment Survey (SWAY) reported a high impact of sickle cell disease (SCD) on patients' daily lives globally. In this study, we analyzed whether the reported burden differed between patients from the USA (n = 384) and other high-income (HI; n = 820) or low- to middle-income (LMI; n = 941) countries. We assessed symptoms and complications, incidence/management of vaso-occlusive crises (VOCs), treatment utilization/satisfaction, and the impact of SCD on education/employment. Certain symptoms (bone aches, insomnia, and joint stiffness) and complications (swollen/painful fingers/toes, gallstones, vision problems, blood clots, and asthma) were reported proportionally more by patients in the USA than in the HI/LMI countries. Self-reported VOCs were more comm</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-22T12:10:52.504Z</modification><creation>2025-04-06T00:13:11.958Z</creation></dates><accession>S-EPMC9540420</accession><cross_references><pubmed>35472249</pubmed><doi>10.1002/ajh.26576</doi></cross_references></HashMap>